Adjuvant Therapy of Breast Cancer IV

Adjuvant Therapy of Breast Cancer IV edited by Hans-Jörg Senn, Richard D. Gelber, Aron Goldhirsch, Beat Thürlimann.

Advances in breast cancer research, achieved through the progress of knowledge and development of new therapies, have been translated into improved quality of care for breast cancer patients. Clinical investigations and clinical trials have made the largest contribution to the body of knowledge that...

Full description

Saved in:
Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Senn, Hans-Jörg (Editor), Gelber, Richard D. (Editor), Goldhirsch, Aron (Editor), Thürlimann, Beat (Editor)
Format: eBook
Language:English
Published: Berlin, Heidelberg : Springer Berlin Heidelberg : Imprint: Springer, 1993.
Edition:1st ed. 1993.
Series:Recent Results in Cancer Research, 127
Springer eBook Collection.
Subjects:
Oncology  .
Surgery.
Gynecology .
Pathology.
Electronic resources (E-books)
Online Access:Click to view e-book
Holy Cross Note:Loaded electronically.
Electronic access restricted to members of the Holy Cross Community.
Table of Contents:
  • I. Biological Mechanisms and Models
  • Kinetic Concepts in the Treatment of Breast Cancer
  • Tumor Stem Cells and the Curability of Early Human Breast Cancer
  • A New Paradigm for Breast Cancer
  • A Laboratory Model To Explain the Survival Advantage Observed in Patients Taking Adjuvant Tamoxifen Therapy
  • Growth Factors and Angiogenesis in Breast Cancer
  • Mechanisms of Treatment Failure
  • Expression of the MDR1 Gene (P-Glycoprotein) in Breast Cancer
  • II. Prognosis and Prediction of Response
  • Prognosis of Breast Cancer Patients: How To Use What?
  • DNA Flow Cytometry Measurements and Their Clinical Relevance in Node-Negative Breast Cancer Patients
  • Review of Proliferative Variables and Their Predictive Value
  • Critical Review of Growth Factors as Clinical Tools in Primary and Metastatic Breast Cancer
  • Prognosis and Prediction for Early Breast Cancer
  • III. Primary Therapy for Early Breast Cancer
  • Trials of Breast Conservation: A Critical Review of All Options
  • Selection and Technique for Lumpectomy
  • Salvage Treatment After Local Breast Cancer Relapse
  • Primary Chemotherapy for Resectable Breast Cancer
  • IV. Radiation Therapy as Part of Primary Treatment
  • Radiation Therapies for Breast Cancer: Current Knowledge of Advantages and Disadvantages
  • How To Combine Adjuvant Chemotherapy and Radiation Therapy
  • Factors Which Predict Breast Relapse
  • Summary Report: Radiation Therapy as Part of Primary Treatment
  • V. Adjuvant Systemic Therapy: Overview and Improvement of Therapy
  • Systemic Treatment of Early Breast Cancer by Hormonal, Cytotoxic, or Immune Therapy: 133 Randomised Trials Involving 31000 Recurrences and 24 000 Deaths Among 75 000 Women (Summary)
  • What Did We Learn from the Results of the International Overview about the Effects of Endocrine Therapy?
  • The World Overview at 10 Years: What Did We Learn about the Results of Chemotherapy?
  • From the Overview to the Patient: How To Interpret Meta-analysis Data
  • High-Dose Adjuvant Chemotherapy for High-Risk Breast Cancer
  • Maintenance Tamoxifen After Induction Postoperative Chemotherapy in Node-Positive Breast Cancer Patients: The Eastern Cooperative Oncology Group Trials
  • Adjuvant Systemic Therapy: Overview
  • VI. Quality-of-Life Considerations in the Adjuvant Setting
  • Assessment of Quality of Life and Benefits from Adjuvant Therapies in Breast Cancer
  • Coping and Survival in Early Breast Cancer: An Update
  • How To Compare Quality of Life of Breast Cancer Patients in Clinical Trials
  • Psychosocial Issues in Breast Cancer Clinical Trials
  • Quality-of-Life Considerations in the Adjuvant Setting: Critical Review
  • VII. Long-Term Toxicity and Economic Aspects
  • Long-Term Sequelae from Adjuvant Chemotherapy
  • Long-Term Toxicity of Tamoxifen
  • New Endocrine Agents for the Treatment of Breast Cancer
  • Financial Costs, Benefits, and Patient Risk Preferences in Node-Negative Breast Cancer: Insights from a Decision Analysis Model
  • Long-Term Toxicity and Economic Aspects: Critical Review
  • VIII. Conclusion
  • Adjuvant Therapy of Primary Breast Cancer: Closing Summary.

Similar Items